Enhanced activation of the LTB4/BLT1 pathway occurs in conditions associated with pathologic intestinal inflammation as observed in inflammatory bowel disease (IBD) and colonic adenocarcinoma (16–18). This evidence concerns the gene LTB4R and inflammatory bowel disease.